Peripheral neuropathy in cancer patients.
Corbo
M
M
Department of Neurology, University of Milan, Scientific Institute San Raffaele Hospital, Milan, Italy.
Balmaceda
C
C
D000970:Antineoplastic Agents / Q000009:adverse effects; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000209:etiology; D003937:Diagnosis, Differential; D004576:Electromyography; D006801:Humans; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D009408:Nerve Compression Syndromes / Q000175:diagnosis / Q000209:etiology; D009410:Nerve Degeneration; D009431:Neural Conduction; D009460:Neurologic Examination; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D010266:Paraproteins / Q000276:immunology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D011832:Radiation Injuries / Q000175:diagnosis / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D012678:Sensation Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology; D012684:Sensory Thresholds
D000970:Antineoplastic Agents; D010266:Paraproteins